Purpose. Construction and validation of a fall risk prediction model specific to inpatients receiving fall risk-increasing drugs (FRIDs) are described.
ach year approximately 1 million people in the United States fall in hospitals, with estimates of the incidence of inpatient falls ranging from 2.2 to 10.0 per 1,000 patient-days. [1] [2] [3] [4] Fall-related injuries include fractures, lacerations, and internal bleeding, with implications for additional healthcare utilization or accidental deaths. 1, 5 The fatality risk associated with falls among inpatients is not negligible, with roughly 11,000 fall-related inpatient deaths occurring each year in the United States. 6 According to investigations on adverse events in hospitals, about one third of falls are preventable. 5, 7 Efforts to reduce fall occurrences have included the implementation of risk assessment tools, [8] [9] [10] predictive models, 2, 11 and clinical intervention programs. 3, 4, 7 However, compared with fall risk in ambulatory care, fall risk in hospitalized patients remains understudied, 5 and most intervention programs have focused on other institutional settings such as nursing homes. 7 In particular, despite the role of pharmacotherapy as a known contributor to fall risk in hospitalized patients, 12, 13 investigation of patients receiving fall risk-increasing drugs (FRIDs) has been limited. Focusing on inpatients who receive FRIDs would allow detailed examination of the role of FRIDs in overall fall risk, offering an opportunity for clinicians to make specific modifications in pharmacotherapy. Considering the importance of fall prevention, fall risk prediction models would allow clinical staff to prioritize patients for intervention, but research on models that can guide preventive action in response to realtime clinical data is lacking.
The study described here aimed to construct a dynamic electronic health record (EHR)-based fall risk prediction model specific to hospitalized patients who receive FRIDs during any of the first 5 days of hospital admission. In addition, we compared the predictive performance of the dynamic risk model with a model based on the widely used Morse Fall Scale (MFS). 9 Our study was part of a larger effort to develop a complexity score (C-Score) that aggregates probability data regarding 16 preventable adverse drug events to support pharmacists' expanding roles in population-based medication therapy management. 14 
Methods
Design and study population. We constructed a retrospective cohort of hospitalized patients using inpatient EHR data from the 2 largest University of Florida (UF)-affiliated hospitals: UF Health Shands (852 beds) and UF Health Jacksonville (695 beds). Data were extracted from the records of patients admitted during the period January 2012-October 2013 (UF Health Shands) or March 2013-October 2013 (UF Health Jacksonville).
We included all inpatients who were 18 years of age or older on admission and received at least 1 FRID during any of the first 5 hospital days. Thus, the reported fall rates and risk factors are specific to patients with FRID exposures. We excluded patientdays on which ventilation or continuous infusion of an immobilizing sedative agent (i.e., propofol, dexmedetomidine, midazolam, vecuronium, rocuronium, atracurium, cisatracurium, or succinylcholine chloride) was
KEY POINTS
• The successful development and validation of a fall risk prediction model targeting hospital inpatients who receive at least 1 fall risk-increasing drug are described.
• More than 20 risk factors that can be automatically extracted from electronic health records (EHRs) contributed to prediction of inpatient falls, resulting in an unbiased C statistic of 0.69.
• The new EHR-based fall risk prediction model identified patients at high risk more accurately than the Morse Fall Scale.
documented. Patients who had falls could still be included in the study cohort. Ascertainment of outcomes. Data on fall occurrences were extracted from the hospitals' automated incident reporting system, which is used throughout the UF Health system to report adverse events. 15 Per hospital policy, all falls must be reported and documented in the reporting system. We did not distinguish fall locations or reasons, such as tripping or falling from a stretcher or table, when counting fall events.
Ascertainment of FRID use and risk factors for falls. We identified and stratified risk levels of FRIDs using the Agency for Healthcare Research and Quality (AHRQ) Fall Prevention Toolkit, 1 the American Geriatric Society's Beers criteria, 16 and expert opinion. Drugs were classified using the AHFS therapeutic drug classification system 17 18 We extracted data on FRID exposures from inpatient electronic medication administration records.
To research fall risk factors, we identified formal studies on fall risk or fall prevention referenced in PubMed, AHRQ's National Guideline Clearinghouse, and drug monographs and conducted a manual review of the references listed in those sources. 19 We presented the final set of risk factors to a national technical expert panel that had been assembled to guide the aforementioned larger project 14 For some risk factors, we allowed for a "look-back" period of up to 1 year and collected information from both inpatient and outpatient records, depending on the expected effect on the outcome (see Appendix C for details). Given that the average length of stay in a U.S. hospital is 4.5 days, 20 we extracted risk information for the first 5 hospital days and predicted falls on the applicable following day (i.e., on hospital day 2, 3, 4, 5, or 6). Essentially, for each hospital day, we developed a set of risk factors derived from varying risk factor-specific look-back periods to predict fall risk on the subsequent day. To address missing data for risk factors, we used either a missing-data indicator or simple imputation. 20 For instance, we used missing-data indicators for hemoglobin value and mobility because of those factors' predictive association with falls in univariate analyses. On the other hand, to address data missingness for total MFS score, blood pressure levels, and blood glucose measurements, we imputed values representing no risk for falls, no hypotension, and no hypoglycemia, respectively, given the small number and nonpredictive properties of these missing values in univariate analyses.
Statistical analysis. We conducted univariate analyses to examine crude associations between risk factors and fall events. For low-frequency risk factors that shared common pathways in causing falls and for which similar strengths of association were demonstrated in univariate analysis, we created composite variables. For example, we generated a "comorbidity predisposition" variable that combined 11 diagnoses related to falls and a past history of falling. In addition, we decided to exclude some variables if associated measurements appeared unreliable or had no value in fall prediction (e.g., notation of a secondary diagnosis or use of i.v. therapy in MFS assessments). With the selected candidate set of risk factors, we next conducted a cluster analysis constructed to identify clusters until 75% of total variation was accounted for. In each identified cluster, we chose the risk factor with the strongest fall prediction properties. We then examined the interaction between a risk factor and the day of hospitalization to see if the effect of a risk factor varied by hospital day. Because the associations between risk factors and falls were stable across the evaluated 5 hospital days, we opted to build a single prediction model. To account for clustering and adjust for repeated measures within the same admission, we used generalized estimating equations for the final model to generate odds ratios (ORs) and 95% confidence intervals (CIs). 21 We used multivariate logistic regression to model the relationship be- No. (%) after excluding patient-days on which documentation of race was "unknown or patient refusal" (n = 2,627). Encompassed a history of falling and 11 past diagnoses: confusion, disorientation, and impulsivity; dizziness and vertigo; hallucinations; visual impairment; hearing loss; vestibular dysfunction; language impairment; orthostatic hypotension; cerebrovascular accident; Parkinson's disease; and seizure disorders. 
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tween fall risk factors, as documented in data compiled from a given hospital day (or preceding days), and inpatient falls that occurred on the subsequent day. Given its nonlinear relationship with falls, the effect of age was modeled using restricted cubic regression splines. To optimize model fit, we built 4 different models: (1) a full model including a full set of risk factors, (2) a parsimonious model, developed via a fast backward elimination technique, that retained all variables with a p value of <0.15, 22 (3) a reduced model with variables that were retained in at least 40 of 100 backward elimination processes, which were repeated by bootstrap resampling, 23 and (4) an expert model that included variables that were selected a priori by our work group. Discrimination and predictive performance of models were assessed using a C-statistic analysis.
Because model performance can be biased or optimistic due to overfitting, we conducted an internal validation to ensure that predictions were valid for patients who were not included in the sample used for model development. 24 To derive optimismcorrected (unbiased) C statistics, we refitted model parameters from 100 bootstrap resamples to the original data set. 23, 24 We accepted a model if the unbiased C statistic fell into the 95% CI for the original C statistic. We used the Akaike information criterion (AIC) to choose the best-fitting model.
Finally, we used beta regression coefficient values from the validated model to calculate a risk score for each admission. Predictive performance and risk score distribution with use of our model were compared with values derived through use of an MFS model that included the total MFS score, a sum of the original 6 MFS items (history of falling, secondary diagnosis, ambulatory aid, i.v. therapy or i.v. access, gait, and mental status [i.e., "overestimates or forget limits"]). All statistical analyses were conducted using SAS, version 9.4 (SAS Institute, Cary, NC). The study was approved by the UF institutional review and privacy boards.
Results
Sample characteristics. For the period January 2012-October 2013, we identified a total 75,036 hospitalizations at UF Health Shands and UF Health Jacksonville. With a mean ± S.D. of 2.94 ± 1.51 hospital days per admission, 466 falls occurred during the total of 220,904 days of hospitalization (2.11 falls per 1,000 patientdays). The distribution of fall events by hospital day was as follows: day 2, 123; day 3, 115; day 4, 100; day 5, 80; and day 6, 48. Most hospital days were attributed to patients who were white (n = 146,039, 66.11%), had a mobility assessment that did not contain notations such as "bed in chair position" or "in bed" (n = 122,593, 55.50%), and/ or were located outside of the intensive care units (n = 201,810, 91.36%). The mean ± S.D. age was 54.61 ± 18.23 years, and less than half of the study population (n = 101,653, 46.02%) was male. Across the first 5 hospital days, the median number of administered high-risk FRIDs was 2 (interquartile range [IQR], 1-3), and the median MFS score was 45 (IQR, 35-60) ( Table 1) .
Inpatient falls associated with risk factors. Strong independent predictors of inpatient falls included a higher number of high-risk FRIDs (OR for 1-unit increase, 1.08; 95% CI, 1.01-1.14), administration of a high versus low dose of 1 Table 2 ). Age, which was assessed using restricted cubic spline regression, was a strong predictor of falls (p = 0.03, Figure 1 ). In the full model, a missing-data indicator for mobility assessment (OR, 1.78; 95% CI, 1.30-2.45) or hemoglobin level (OR, 2.86; 95% CI, 1.59-5.15) was also found to be significantly associated with inpatient falls.
Predictive model development and validation. Of the 466 falls that occurred in patients in the 50th and 90th percentiles of predicted fall risk, 364 and 144 (78.1% and 30.9%, respectively) were captured by our model (Figure 2 ). By comparison, 94 of 466 falls (20.2%) were correctly grouped in the 90th percentile of fall risk using the MFS model ( Figure 3 ). When using our full model, we found that 1 in 166 admissions were correctly categorized in the 90th percentile for fall risk.
Discussion
In our study, in which we employed EHR data from the records of more than 75,000 patients admitted to 2 large academic hospitals, we built a dynamic risk model for inpatient falls and compared its predictive performance with that of the MFS, which is one of the most commonly used fall risk scales and has established reliability and validity. 1 In our study population of patients who received at least 1 FRID, we evaluated a multitude of risk factors that contributed to predicting inpatient falls during the first 5 days of hospitalization. Pharmacotherapyrelated factors such as administration of multiple FRIDs and use of high FRID doses, as well as patient-level risk factors, were significant predictors of falls. By summarizing the predictive contribution of risk factors, our model captured about 50 more of the 466 evaluated falls than the MFS model when focusing on high-risk patients in the 90th percentile of risk scores.
The improvement in predictive validity provided by our model versus the MFS (unbiased C statistic, 0.69 versus 0.62) is notable given that the latter model has been validated in various settings. 25 This notwithstand-ing, we acknowledge that the predictive performance of the model is not on par with models for other hospital adverse events that we 14 and others have developed (e.g., C statistics for models for predicting acute kidney injury ranged from 0.71 to 0.83 26, 27 ). Our model's subpar performance might be explained in part by the circumstantial and oftentimes accidental nature of falls, which might have resulted in mediocre discrimination. 11, 28 Risk factors such as age and comorbidity predisposition had similar effects on fall risk, as described by other prediction models developed at teaching hospitals. 2, 11 However, differences in institution-specific protocols or practices that can affect the association and interplay of risk factors should be considered when comparing the results achieved with our model versus other models. For example, we found a positive association between an increase in hemoglobin level and inpatient falls, which is contradictory to previous findings that have associated anemia with an increased risk of falls. 29 This discrepancy might be explained by proactive and careful monitoring of anemic patients. Following this notion, some risk factors with no or weak association in our model might be due to preventive measures implemented by clinical staff or corrections made for other risk factors for falls that share a causal pathway.
Our study findings have several clinical implications. First, we found that for each additional FRID administered, there was an ~8% increase in the odds of falling. Administration of multiple FRIDs has received attention in research on fall risks. 30, 31 Our study reaffirmed the importance of monitoring patients taking multiple FRIDs, showing an incremental risk increase with the addition of FRIDs to a patient's regimen, which can be exacerbated by selection of high-risk FRIDs. Unfortunately, we were not able to examine the effects of individual drugs or drug classes on fall risk and recommend future research with larger samples to address this important topic. In selecting FRIDs, we followed previously published evidence but noted some differences from previous prediction models. For example, the STRATIFY tool 30 included diuretics, which we classified as lowrisk drugs, and the Johns Hopkins Fall Risk Assessment Tool 31 included laxatives, which were not considered in our study. We noted a strong association between high doses of high-risk FRIDs and inpatient falls. Additional evidence on dose-response relationships for FRIDs would allow careful optimization of pharmacotherapy to lower fall risk. Second, the fall probabilities (summarized in the risk score) generated from our prediction model allow prioritization of patients for preventive actions. For example, depending on available resources, a hospital might focus interventions on patients in the 5th or 9th risk-score decile, which would capture 31% or 78% of those at risk for fall events. Compared with the MFS model, our model correctly grouped an additional 11% of falls in the 9th risk-score decile, but this required adding more risk factors and thus more involved data collection. However, with the benefits of increased accuracy in fall risk prediction (resulting in more opportunities for interventions) and automated EHR data extraction, the implementation burden of using our model might be acceptable.
Our study had several strengths and limitations. First, we established our study cohort using data from a large regional inpatient sample including patients at 2 health centers with a diverse case mix. Nevertheless, since local clinical practices, the availability of formulary drugs and fall prevention interventions, and even data documentation in the EHR vary by institution, we expect that the reported ORs are not fully generalizable beyond the 2 study sites. Thus, an important future step is to validate this model in other hospitals, allowing use of customized regression parameters to estimate patient risk scores. Second, we measured a comprehensive set of risk factors and timed risk factor ascertainment considering their acute or chronic effects on fall risk by taking advantage of the wealth of realtime EHR data. Third, all selected data are typically available within discrete fields in EHRs, allowing implementa- tion of the first fully automated fall prediction score. It should be noted that for real-time implementation, our use of diagnosis codes, which are typically assigned after discharge, would need to be replaced by discrete diagnosis information on patients' problem lists. As a federal requirement for maintenance of an up-to-date problem list was only recently implemented, 32 we opted to rely on diagnosis codes instead. Fourth, in our selection of risk factors, we emphasized risk factors that are amenable to clinicians' intervention. Examples that might be a good lead for preventive action include low blood pressure, exposure to high-dose or multiple high-risk FRIDs, hypoglycemia, and recognition and management of confusion.
Fifth, while real-time EHRs offer generally comprehensive information, 2 scenarios can lead to missing values. First, the maximum 1-year look-back period used to capture disease history might not have been sufficiently long and required that patients received their outpatient services in our health system. Second, clinical tests are usually ordered in certain clinical contexts and, thus, their missingness is not random. To optimize the predictive validity of our model, we addressed missing data by using imputation or a missing-data indicator in those instances where missingness was informative (e.g., data on mobility were missing). Finally, in an effort to restrict risk factors to variables that can be automatically retrieved from discrete fields in EHR systems, we could not include all important risk factors in our prediction models. For example, urinary incontinence has been described as a risk factor for falls 33, 34 but was not ascertainable from discrete fields in the EHR system used at the study sites. For future research using EHRs, natural language processing may enhance the extraction of information written in notes, 35 allowing the development of a more robust predictive model.
Conclusion
The proposed risk model for inpa- Figure 2 . Predictive performance of the full model, as determined by analysis of 466 documented fall events in the first 5 days after hospital admission during a total of 220,904 days of hospitalization at the 2 study sites. In panel A, the blue line represents the number of admissions during which at least 1 fall was documented; the bars indicate the counts of falls sorted by risk score percentile. In panel B, the solid line denotes the receiver operating characteristic (ROC) curve, and the dashed line represents the line of no discrimination; the area under the ROC curve represents the optimism-corrected (unbiased) C statistic that was calculated by refitting model parameters from 100 bootstrap resamples to the original data set (0.702; 95% confidence interval, 0.678-0.727). The validated C statistic was 0.686. concentration at or up to 30 days prior to modeling day is greater than 2,000 pg/mL 12. Visual or language impairment (up to 1 day prior to modeling day) a. Speech = "slurred," "delayed responses," "expressive aphasia," "receptive aphasia," or "global aphasia" OR b. Eye assessment = "blurry vision," "diplopia," or "peripheral vision absent" 13. Hypoglycemic event (up to 1 day prior to modeling day) a. 
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